Homo sapiens Protein: PPM1K | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-29592.6 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | PPM1K | ||||||||||||||||||||||
Protein Name | protein phosphatase, Mg2+/Mn2+ dependent, 1K | ||||||||||||||||||||||
Synonyms | |||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000295908 | ||||||||||||||||||||||
InnateDB Gene | IDBG-29590 (PPM1K) | ||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | Regulates the mitochondrial permeability transition pore and is essential for cellular survival and development. {ECO:0000269PubMed:17374715}. | ||||||||||||||||||||||
Subcellular Localization | Mitochondrion matrix {ECO:0000269PubMed:17336929, ECO:0000269PubMed:17374715}. | ||||||||||||||||||||||
Disease Associations | Maple syrup urine disease, mild variant (MSUDMV) [MIM:615135]: A mild form of maple syrup urine disease, a metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated. MSUDMV is characterized by increased plasma levels of branched-chain amino acids (BCAA) apparent at birth. Treatment with a low-protein diet free of BCAA can result in normal psychomotor development and lack of metabolic episodes. {ECO:0000269PubMed:23086801}. Note=The gene represented in this entry is involved in disease pathogenesis. | ||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 2 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR001932
Protein phosphatase 2C (PP2C)-like domain |
||||||||||||||||||||||
PFAM |
PF00481
PF07228 |
||||||||||||||||||||||
PRINTS | |||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART |
SM00331
SM00332 |
||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | |||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q8N3J5 | ||||||||||||||||||||||
TrEMBL | V9GYS8 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 152926 | ||||||||||||||||||||||
UniGene | Hs.43744 | ||||||||||||||||||||||
RefSeq | XP_005262832 | ||||||||||||||||||||||
HUGO | HGNC:25415 | ||||||||||||||||||||||
OMIM | 611065 | ||||||||||||||||||||||
CCDS | |||||||||||||||||||||||
HPRD | 15167 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AC097484 AC107067 AC108213 | ||||||||||||||||||||||
GenPept | |||||||||||||||||||||||